Trends in Absolute DAA Regimen Insurance Denials in the United States

Absolute denials of direct-acting antiviral (DAA) treatment regimens in patients infected with hepatitis C virus (HCV) have remained high and increased over time regardless of patient insurance type, according to results published in Open Forum Infectious Diseases.

Of the 9025 participants with DAA prescriptions, 3200 were absolutely denied treatment. Participants with commercial insurance were more likely to be denied compared with participants with Medicaid or Medicare (52.4% vs 34.5% or 14.7%, respectively).

READ MORE

Screening for Hepatitis C Climbs in Colorado

An analysis by the Colorado Health Institute of
newly available information from the state’s All
Payer Claims Database (APCD) reveals the rate of
Coloradans getting screened for the hepatitis C virus
nearly tripled between 2011 and 2016.
Screening for hepatitis C has been a focus of public
health efforts in recent years. An estimated 3.5
million Americans are living with hepatitis C, but
the U.S. Centers for Disease Control and Prevention
(CDC) estimates that half of them aren’t even aware
they have it.
This report analyzes who is getting screened for
hepatitis C in Colorado as well as the key policy
actions and medical advances that are driving the
rise in screening.

READ MORE